Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “18F-FDG PET”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT02899325
What this trial is testing

FDGal PET/CT to Detect Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Liver Disease
British Columbia Cancer Agency
Not applicableStudy completedNCT02394743
What this trial is testing

Correlation Between Estimated Glomerular Filtration Rate(eGFR) and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)

Who this might be right for
Atherosclerosis
Korea University 360
Not applicableUnknownNCT03839706
What this trial is testing

Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 20
Early research (Phase 1)Study completedNCT00135161
What this trial is testing

Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
University Hospital, Ghent 40
Not applicableActive Not RecruitingNCT01996046
What this trial is testing

FDG PET/CT in Breast Cancer Bone Mets

Who this might be right for
Estrogen Receptor Positive Breast CancerBone Metastases
University of Pennsylvania 75
Not applicableLooking for participantsNCT05541744
What this trial is testing

The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Buddhist Tzu Chi General Hospital 120
Testing effectiveness (Phase 2)WithdrawnNCT05423197
What this trial is testing

89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC

Who this might be right for
Head-and-neck Squamous Cell Carcinoma
Andrei Iagaru
Large-scale testing (Phase 3)Not Yet RecruitingNCT01394679
What this trial is testing

99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer

Who this might be right for
Lung Cancer
Cell>Point LLC 154
Testing effectiveness (Phase 2)UnknownNCT04502303
What this trial is testing

18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease

Who this might be right for
Crohn Disease
Peking Union Medical College Hospital 30
Not applicableStudy completedNCT01665703
What this trial is testing

Imaging Correlates of Renal Cell Carcinoma Biological Features

Who this might be right for
Renal Cell Carcinoma
UNC Lineberger Comprehensive Cancer Center 17
Not applicableStudy completedNCT03188354
What this trial is testing

Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinCentral Nervous System Neoplasms
Norwegian University of Science and Technology 3
Not applicableStudy completedNCT02078141
What this trial is testing

18F-deoxyglucose (FDG) PET-CMD

Who this might be right for
Patients With Idiopathic Dilated Cardiomyopathy
Nantes University Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00771381
What this trial is testing

Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer

Who this might be right for
Breast Neoplasm
AHS Cancer Control Alberta 23
Post-approval studies (Phase 4)Looking for participantsNCT06706921
What this trial is testing

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstatic Neoplasms, Castration-ResistantMetastatic Prostate Cancer+8 more
VA Greater Los Angeles Healthcare System 15
Not applicableStudy completedNCT00958087
What this trial is testing

Cardiac Sarcoidosis and FDG-PET

Who this might be right for
SarcoidosisDilated Cardiomyopathy
Kurume University 20
Not applicableEnded earlyNCT01815112
What this trial is testing

Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentVascular Dementia
Centre Hospitalier Universitaire, Amiens 60
Testing effectiveness (Phase 2)Study completedNCT00375830
What this trial is testing

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

Who this might be right for
Cancer
Stanford University 114
Not applicableUnknownNCT05796011
What this trial is testing

PET-CT-based Study of Central Mechanisms of Cortical Metabolism in 18F-FDG and 18F-AV1451 Age-related Deafness

Who this might be right for
Age-related Hearing LossPET-CT
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Testing effectiveness (Phase 2)UnknownNCT05709171
What this trial is testing

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

Who this might be right for
GEP-NETNeuroendocrine TumorsNeuroendocrine Carcinoma+1 more
Rigshospitalet, Denmark 200
Not applicableUnknownNCT01374659
What this trial is testing

Diagnostic Utility of [18F]-FDG-PET/CT and [124I]-PET/CT for Detection of Recurrence in Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid CancerRecurrence
Korean Association of Endocrine Surgeons 50
Next Page